RBC Capital Markets adjusted their outlook on Morgan Stanley (NYSE:MS) shares, raising the price target from $122.00 to $142.00. The firm maintained a Sector Perform rating on the stock. The upgrade comes as Morgan Stanley's stock trades near its 52-week high of $136.

In a report released yesterday, Deane Dray from RBC Capital maintained a Hold rating on Lennox International (LII – Research Report), with a

Swatch Group AG (UHR:SW) (OTC: OTC:SWGAY) shares were downgraded by Morgan Stanley (NYSE:MS) from Equalweight to Underweight. The firm also reduced the price target to CHF145.00 from the previous CHF175.

Exelixis Inc (EXEL) stock saw a modest uptick, ending the day at $32.73 which represents a slight increase of $0.35 or 1.08% from the prior close of $32.38. The stock opened at $32.92 and touched a low of $32.

Amit Zavery; President, Chief Operating Officer, Chief Product Officer; ServiceNow Inc Michael Cikos; Analyst; Needham & Company Inc.

Wall Street analysts largely maintained bullish views on IBM ( NYSE: IBM) after the tech giant's fourth-quarter results and outlook surpassed expectations. Shares of IBM jumped about 9% premarket on Thursday. RBC Capital Markets kept its Outperform rating and raised the price target on the shares to $276 from $250.

In a report released today, Sebastian Kuenne from RBC Capital maintained a Hold rating on ABB Ltd (0NX2 – Research Report), with a price target

Texas Capital Bancshares (NASDAQ:TCBI – Get Free Report) had its price target dropped by analysts at Stephens from $102.00 to $97.00 in a report released on Tuesday,Benzinga reports. The brokerage currently has an “overweight” rating on the bank’s stock.

Like other recent pools of securitized mortgages located in the Los Angeles County area, any loans that exhibited material damage from the fires were removed from the pool before closing.

The Fed meets this week, but the probability of another cut at Wednesday's meeting seems low amid elevated inflation and growth data, said Matt Fabian, a partner at Municipal Market Analytics.

Dyne Therapeutics Inc (DYN) stock saw a decline, ending the day at $13.67 which represents a decrease of $-0.05 or -0.36% from the prior close of $13.72. The stock opened at $13.74 and touched a low of $13.

Tech stocks suffered on "worries that Beijing is becoming increasingly competitive in the high-stakes artificial intelligence race," said José Torres, senior economist at Interactive Brokers.